Two Sigma Advisers’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Sell |
533,771
-135,400
| -20% | -$280K | ﹤0.01% | 1390 |
|
|
2025
Q1 | $1.47M | Sell |
669,171
-154,700
| -19% | -$340K | ﹤0.01% | 1282 |
|
|
2024
Q4 | $1.26M | Buy |
823,871
+12,500
| +2% | +$19.1K | ﹤0.01% | 1354 |
|
|
2024
Q3 | $1.61M | Buy |
811,371
+697,871
| +615% | +$1.39M | ﹤0.01% | 1185 |
|
|
2024
Q2 | $397K | Buy |
113,500
+71,400
| +170% | +$250K | ﹤0.01% | 1971 |
|
|
2024
Q1 | $117K | Buy |
42,100
+3,100
| +8% | +$8.59K | ﹤0.01% | 2288 |
|
|
2023
Q4 | $66.3K | Sell |
39,000
-4,500
| -10% | -$7.65K | ﹤0.01% | 2373 |
|
|
2023
Q3 | $44.8K | Sell |
43,500
-18,000
| -29% | -$18.5K | ﹤0.01% | 2285 |
|
|
2023
Q2 | $71.3K | Sell |
61,500
-1,400
| -2% | -$1.62K | ﹤0.01% | 2242 |
|
|
2023
Q1 | $95K | Sell |
62,900
-17,900
| -22% | -$27K | ﹤0.01% | 2390 |
|
|
2022
Q4 | $202K | Buy |
80,800
+54,100
| +203% | +$135K | ﹤0.01% | 2187 |
|
|
2022
Q3 | $113K | Buy |
+26,700
| New | +$113K | ﹤0.01% | 2293 |
|
|
2020
Q1 | – | Sell |
-14,100
| Closed | -$331K | – | 2506 |
|
|
2019
Q4 | $331K | Buy |
+14,100
| New | +$331K | ﹤0.01% | 2033 |
|